title: Application of DNA methylation biomarkers for endometrial cancer management.
abstract: It has become clear that aberrant gene expression, via alterations in promoter methylation or histone acetylation, is a contributing factor for carcinogenesis, perhaps as important as genetic mutation. This is particularly evident in endometrial cancer, in which multiple genes are silenced through hypermethylation. In this review, we discuss the field of epigenetics and relevant techniques to characterize methylation and acetylation alterations. The CpG island methylator phenotype, epimutations and the effects of aging on methylation are also discussed. In endometrial cancer there is evidence that hypermethylation of relevant genes can be reversed using epigenetic inhibitors, resulting in re-expression of silenced genes. Preliminary data also suggest that a panel of methylation biomarkers could be useful for diagnosis and even screening in selected populations at high risk. This disease is particularly well suited for such a strategy given that the endometrium is readily accessible for testing and endometrial cancer precursors are well defined.
authors.affiliation: Department of Biomedical Science, Mercer University School of Medicine at Savannah, 4700, Waters Avenue, Savannah, GA 31404, USA. jiang_s@mercer.edu
authors.forename: Shi-Wen
authors.initials: SW
authors.lastname: Jiang
authors.forename: Jinping
authors.initials: J
authors.lastname: Li
authors.forename: Karl
authors.initials: K
authors.lastname: Podratz
authors.forename: Sean
authors.initials: S
authors.lastname: Dowdy
mesh_terms: D000818:Animals; D015415:Biomarkers; D004247:DNA / Q000378:metabolism; D019175:DNA Methylation; D016889:Endometrial Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D012008:Recurrence; D018570:Risk Assessment
chemical_list: D015415:Biomarkers; D004247:DNA
references.citation: Nat Genet. 2004 May;36(5):497-501
references.pmid: 15064764
references.citation: Pathol Int. 2005 Nov;55(11):707-15
references.pmid: 16271083
references.citation: Cancer. 2003 Feb 15;97(4):1002-9
references.pmid: 12569599
references.citation: Clin Cancer Res. 2007 Mar 15;13(6):1634-7
references.pmid: 17363514
references.citation: Clin Genet. 2007 Mar;71(3):232-7
references.pmid: 17309645
references.citation: J Natl Cancer Inst. 2000 Apr 5;92(7):564-9
references.pmid: 10749912
references.citation: Gynecol Oncol. 2002 Jul;86(1):62-8
references.pmid: 12079302
references.citation: Cancer Res. 1998 Dec 1;58(23):5489-94
references.pmid: 9850084
references.citation: Mol Cancer Ther. 2005 Jan;4(1):169-75
references.pmid: 15657363
references.citation: Cancer. 1954 Nov;7(6):1185-90
references.pmid: 13209518
references.citation: Clin Cancer Res. 2007 Oct 15;13(20):6093-8
references.pmid: 17947473
references.citation: Nat Rev Cancer. 2004 Dec;4(12):988-93
references.pmid: 15573120
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6870-5
references.pmid: 9618505
references.citation: JAMA. 1983 Sep 16;250(11):1430-1
references.pmid: 6887466
references.citation: Int J Cancer. 2001 Jan 1;91(1):22-6
references.pmid: 11149415
references.citation: BMC Cancer. 2006 Aug 23;6:212
references.pmid: 16928264
references.citation: Clin Cancer Res. 2004 Feb 1;10(3):1141-9
references.pmid: 14871994
references.citation: Electrophoresis. 2002 Dec;23(24):4072-9
references.pmid: 12481262
references.citation: Nat Genet. 2006 Oct;38(10):1178-83
references.pmid: 16951683
references.citation: N Engl J Med. 2007 Feb 15;356(7):697-705
references.pmid: 17301300
references.citation: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6
references.pmid: 10411935
references.citation: Int J Oncol. 2001 Feb;18(2):323-9
references.pmid: 11172599
references.citation: Ann N Y Acad Sci. 2005;1054:68-77
references.pmid: 16339653
references.citation: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2545-50
references.pmid: 9122232
references.citation: Biochim Biophys Acta. 1981 Apr 27;653(2):204-18
references.pmid: 7225396
references.citation: Methods Mol Biol. 2002;200:71-85
references.pmid: 11951656
references.citation: Gynecol Oncol. 2007 May;105(2):493-500
references.pmid: 17303224
references.citation: Postgrad Med J. 1985;61 Suppl 1:31-3
references.pmid: 4059157
references.citation: Cancer Sci. 2006 Nov;97(11):1267-73
references.pmid: 16965396
references.citation: Cancer Res. 2004 Sep 15;64(18):6476-81
references.pmid: 15374957
references.citation: Nat Clin Pract Oncol. 2005 Dec;2 Suppl 1:S4-11
references.pmid: 16341240
references.citation: J Natl Cancer Inst. 2006 Jul 19;98(14):996-1004
references.pmid: 16849682
references.citation: Expert Rev Mol Diagn. 2007 Sep;7(5):519-31
references.pmid: 17892361
references.citation: Semin Cancer Biol. 1999 Oct;9(5):349-57
references.pmid: 10547343
references.citation: Clin Cancer Res. 2007 May 15;13(10):2882-9
references.pmid: 17504987
references.citation: J Cell Physiol. 2006 Mar;206(3):611-5
references.pmid: 16222700
references.citation: Virchows Arch. 2007 May;450(5):529-37
references.pmid: 17372756
references.citation: Am J Obstet Gynecol. 1988 Apr;158(4):796-807
references.pmid: 2966586
references.citation: Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R65-76
references.pmid: 15809275
references.citation: Gastroenterology. 2007 Jan;132(1):127-38
references.pmid: 17087942
references.citation: Clin Obstet Gynaecol. 1986 Dec;13(4):725-38
references.pmid: 3791827
references.citation: Curr Top Microbiol Immunol. 2006;310:141-78
references.pmid: 16909910
references.citation: Cancer. 1954 Nov;7(6):1182-4
references.pmid: 13209517
references.citation: Histopathology. 1982 Sep;6(5):493-510
references.pmid: 6754573
references.citation: Int J Cancer. 1999 Oct 29;83(3):309-13
references.pmid: 10495421
references.citation: Mol Cancer Ther. 2006 Nov;5(11):2767-76
references.pmid: 17121923
references.citation: Pancreas. 2006 May;32(4):382-9
references.pmid: 16670620
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):882-8
references.pmid: 15159323
references.citation: Recent Results Cancer Res. 1990;118:242-51
references.pmid: 2236840
references.citation: Dis Markers. 2007;23(1-2):89-96
references.pmid: 17325428
references.citation: Methods Mol Biol. 2007;361:25-62
references.pmid: 17172706
references.citation: Clin Cancer Res. 2004 Aug 15;10(16):5546-53
references.pmid: 15328195
references.citation: Lab Invest. 2000 Oct;80(10):1513-22
references.pmid: 11045568
references.citation: Oncogene. 2001 Jun 7;20(26):3348-53
references.pmid: 11423985
references.citation: Gynecol Oncol. 2008 Jan;108(1):27-33
references.pmid: 17920664
references.citation: Biotechniques. 2003 Jul;35(1):146-50
references.pmid: 12866414
references.citation: Cancer Res. 2002 Feb 1;62(3):881-6
references.pmid: 11830547
references.citation: Int J Cancer. 2006 May 1;118(9):2168-71
references.pmid: 16331610
references.citation: Gynecol Oncol. 2005 Oct;99(1):135-41
references.pmid: 16024066
references.citation: Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3329-36
references.pmid: 16740754
references.citation: Cancer. 1957 Mar-Apr;10(2):332-7
references.pmid: 13426989
references.citation: Ann N Y Acad Sci. 2004 Jun;1022:33-9
references.pmid: 15251936
references.citation: Cancer Res. 2008 Apr 15;68(8):2661-70
references.pmid: 18413733
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11757-62
references.pmid: 8876210
references.citation: Biochim Biophys Acta. 1999 May 31;1423(3):O1-O10
references.pmid: 10382540
references.citation: J Clin Oncol. 1996 Feb;14(2):357-61
references.pmid: 8636744
references.citation: Lancet. 2000 Apr 22;355(9213):1404-11
references.pmid: 10791524
references.citation: Clin Cancer Res. 2003 Jun;9(6):2277-87
references.pmid: 12796396
references.citation: Int J Cancer. 2007 Feb 1;120(3):656-63
references.pmid: 17096326
references.citation: J Mol Diagn. 2006 Nov;8(5):582-8
references.pmid: 17065427
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Cancer Detect Prev. 2007;31(1):59-63
references.pmid: 17291695
references.citation: BMC Cancer. 2007 May 02;7:72
references.pmid: 17474983
references.citation: Immunol Cell Biol. 2001 Feb;79(1):18-22
references.pmid: 11168618
references.citation: Clin Cancer Res. 2005 Nov 1;11(21):7728-34
references.pmid: 16278393
references.citation: Ageing Res Rev. 2003 Jul;2(3):245-61
references.pmid: 12726774
references.citation: Clin Cancer Res. 2004 May 15;10(10):3396-400
references.pmid: 15161694
references.citation: J Mol Diagn. 2005 Feb;7(1):8-16
references.pmid: 15681469
references.citation: Hum Mol Genet. 2003 Sep 1;12(17):2209-19
references.pmid: 12915469
references.citation: Carcinogenesis. 2007 Aug;28(8):1672-9
references.pmid: 17449906
references.citation: Int J Oncol. 2004 Dec;25(6):1615-23
references.pmid: 15547698
references.citation: CA Cancer J Clin. 2001 Jan-Feb;51(1):38-75; quiz 77-80
references.pmid: 11577479
references.citation: Mod Pathol. 2006 Sep;19(9):1227-35
references.pmid: 16729014
references.citation: Cancer Treat Res. 1998;94:89-106
references.pmid: 9587684
references.citation: Int J Gynecol Cancer. 1999 Jul;9(4):285-294
references.pmid: 11240781
references.citation: Chin Med J (Engl). 2006 Sep 5;119(17):1469-72
references.pmid: 16989749
references.citation: Anal Biochem. 2003 Jun 15;317(2):259-65
references.pmid: 12758266
references.citation: Cancer Res. 2001 Jan 1;61(1):97-102
references.pmid: 11196205
references.citation: Am J Obstet Gynecol. 1977 Feb 1;127(3):332-3
references.pmid: 835631
references.citation: Am J Epidemiol. 1981 Dec;114(6):873-9
references.pmid: 7315834
references.citation: J Mol Med (Berl). 2006 May;84(5):365-77
references.pmid: 16416310
references.citation: Am J Pathol. 1999 Nov;155(5):1767-72
references.pmid: 10550333
references.citation: Int J Gynecol Cancer. 2004 Sep-Oct;14(5):957-65
references.pmid: 15361209
references.citation: Cancer. 1957 Jan-Feb;10(1):120-3
references.pmid: 13413807
references.citation: In Vivo. 2007 Jan-Feb;21(1):35-43
references.pmid: 17354612
references.citation: Nat Genet. 2000 Sep;26(1):16-7
references.pmid: 10973239
references.citation: Cancer Lett. 2007 Jun 28;251(2):187-98
references.pmid: 17166656
references.citation: Curr Top Microbiol Immunol. 2006;310:45-59
references.pmid: 16909906
references.citation: Oral Oncol. 2007 Oct;43(9):878-86
references.pmid: 17257884
references.citation: Cancer Res. 2002 Apr 15;62(8):2370-7
references.pmid: 11956099
references.citation: Hum Pathol. 2001 Jun;32(6):569-77
references.pmid: 11431710
references.citation: J Biol Chem. 2005 May 6;280(18):17986-91
references.pmid: 15757890
references.citation: FEBS Lett. 1989 Feb 13;244(1):193-8
references.pmid: 2466694
references.citation: Clin Cancer Res. 2002 Dec;8(12):3782-7
references.pmid: 12473590
references.citation: Gynecol Oncol. 2005 Oct;99(1):126-34
references.pmid: 16023706
references.citation: Eur J Cancer. 2000 Dec;36(18):2294-300
references.pmid: 11094302